.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Kanamycin sulfate - Generic Drug Details

« Back to Dashboard
Kanamycin sulfate is the generic ingredient in four branded drugs marketed by Apothecon, Abraxis Pharm, Solopak, Fresenius Kabi Usa, Watson Labs, Loch, Eurohlth Intl Sarl, Intl Medication, Pharmafair, King Pharms, and Warner Chilcott, and is included in twenty NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for kanamycin sulfate. One supplier is listed for this compound.

Summary for Generic Name: kanamycin sulfate

Tradenames:4
Patents:0
Applicants:11
NDAs:20
Drug Master File Entries: see list5
Suppliers / Packaging: see list1
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Clinical Trials for: kanamycin sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apothecon
KANTREX
kanamycin sulfate
INJECTABLE;INJECTION062564-002Sep 21, 1984DISCNNo<disabled><disabled>
Intl Medication
KANAMYCIN SULFATE
kanamycin sulfate
INJECTABLE;INJECTION062466-002Sep 30, 1983DISCNNo<disabled><disabled>
Abraxis Pharm
KANAMYCIN SULFATE
kanamycin sulfate
INJECTABLE;INJECTION062504-002Apr 5, 1984DISCNNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc